Ghent University Academic Bibliography

Advanced

Safety analysis of randomized Belgian phase II trial of extended use of adjuvant temozolomide in newly diagnosed glioblastoma patients

L Renard, PM Clement, F Hammouch, Tom Boterberg UGent, V Verschaeve, N Whenham, C Mitine, D Devriendt and J Baurain (2010) NEURO-ONCOLOGY. 12(Suppl. 3). p.46-47
Please use this url to cite or link to this publication:
author
organization
year
type
conference
publication status
published
subject
in
NEURO-ONCOLOGY
Neuro-Oncology
volume
12
issue
Suppl. 3
pages
46 - 47
conference name
9th Meeting of European-Association-of-NeuroOncology
conference location
Maastricht, The Netherlands
conference start
2010-09-16
conference end
2010-09-19
Web of Science type
Meeting Abstract
Web of Science id
000281184800177
JCR category
CLINICAL NEUROLOGY
JCR impact factor
5.483 (2010)
JCR rank
15/185 (2010)
JCR quartile
1 (2010)
ISSN
1522-8517
language
English
UGent publication?
yes
classification
C3
id
1261077
handle
http://hdl.handle.net/1854/LU-1261077
date created
2011-06-14 11:10:14
date last changed
2011-06-23 14:34:08
@inproceedings{1261077,
  author       = {Renard, L and Clement, PM and Hammouch, F and Boterberg, Tom and Verschaeve, V and Whenham, N and Mitine, C and Devriendt, D and Baurain, J},
  booktitle    = {NEURO-ONCOLOGY},
  issn         = {1522-8517},
  language     = {eng},
  location     = {Maastricht, The Netherlands},
  number       = {Suppl. 3},
  pages        = {46--47},
  title        = {Safety analysis of randomized Belgian phase II trial of extended use of adjuvant temozolomide in newly diagnosed glioblastoma patients},
  volume       = {12},
  year         = {2010},
}

Chicago
Renard, L, PM Clement, F Hammouch, Tom Boterberg, V Verschaeve, N Whenham, C Mitine, D Devriendt, and J Baurain. 2010. “Safety Analysis of Randomized Belgian Phase II Trial of Extended Use of Adjuvant Temozolomide in Newly Diagnosed Glioblastoma Patients.” In Neuro-oncology, 12:46–47.
APA
Renard, L., Clement, P., Hammouch, F., Boterberg, T., Verschaeve, V., Whenham, N., Mitine, C., et al. (2010). Safety analysis of randomized Belgian phase II trial of extended use of adjuvant temozolomide in newly diagnosed glioblastoma patients. NEURO-ONCOLOGY (Vol. 12, pp. 46–47). Presented at the 9th Meeting of European-Association-of-NeuroOncology.
Vancouver
1.
Renard L, Clement P, Hammouch F, Boterberg T, Verschaeve V, Whenham N, et al. Safety analysis of randomized Belgian phase II trial of extended use of adjuvant temozolomide in newly diagnosed glioblastoma patients. NEURO-ONCOLOGY. 2010. p. 46–7.
MLA
Renard, L, PM Clement, F Hammouch, et al. “Safety Analysis of Randomized Belgian Phase II Trial of Extended Use of Adjuvant Temozolomide in Newly Diagnosed Glioblastoma Patients.” Neuro-oncology. Vol. 12. 2010. 46–47. Print.